等待開盤 03-26 09:30:00 美东时间
+0.120
+11.76%
https://www.usatoday.com/story/special/contributor-content/2026/03/25/biotech-company-tivic-health-aims-to-advance-immunotherapy-research-programs/89318926007/
今天 04:44
Tivic Health Systems, Inc. (Nasdaq:TIVC) ("Tivic" or the "Company"), a late-stage immunotherapeutics company, today announced that its Board of Directors has appointed Michael K. Handley as Chief Executive Officer of
03-04 21:37
Initial presentation on January 26, 2026 showcased Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing radiation exposure.FREMONT, CA / ACCESS Newswire / February
02-18 22:18
Tivic Health® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that it delivered an invited presentation at a TechWatch meeting with the Biomedical Advanced Research and
01-28 21:33
Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS) and Neutropenia through wholly owned contract development manufacturing organization (CDMO),
01-12 22:03
Shares of Davis Commodities Ltd (NASDAQ:DTCK) rose sharply in pre-market tradin...
2025-12-26 17:40
Gainers Trinity Biotech (NASDAQ:TRIB) stock moved upwards by 54.7% to $1.38 du...
2025-12-24 01:05
Acquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization (CDMO) subsidiary, Velocity Bioworks™Financing led by 3i, LP includes $16M debt
2025-12-11 22:51
Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage therapeutics company, today announced it has secured an exclusive Techwatch meeting with the Biomedical Advanced Research and Development Authority (BARDA)'s
2025-11-18 21:35